Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Oesophagus cancer link to osteoporosis drug

  • 1 Comment

Long-term use of oral bisphosphonates, a drug used to treat osteoporosis in post-menopausal women, may double the risk of developing oesophagus cancer, research suggests.

Data on around six million UK GP patients was analysed by the University of Oxford and the Medicines and Healthcare products Regulatory Agency. Among those aged 40 and over, 2,954 had oesophageal cancer, 2,018 had gastric cancer and 10,641 had bowel cancer, all diagnosed between 1995 and 2005.

The experts looked at the use of oral bisphosphonates and cancers of the oesophagus, stomach and bowel, taking into account factors such as smoking, alcohol and body mass index.

The results showed that the chance of oesophageal cancer was 30% higher in people with one or more previous prescriptions for oral bisphosphonates compared to people who had never taken the drugs.

The risk was almost double for those who had 10 or more prescriptions compared with those who had had between one and nine.

For those taking the drugs for at least three years (five years on average), the risk was more than double compared with those who had never had a prescription for the drugs.

There were no links between the drugs and stomach or bowel cancer.

  • 1 Comment

Readers' comments (1)

  • yet again any medication for osteoporosis has been highlighted as having a bad side effect, last month it was calcium and heart problems. we will just have to all have crumbling bones!!

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs